Full event video: An Evening With Stephen Lippard
Dr. Lippard is the Arthur Amos Noyes Professor Emeritus of Chemistry at MIT whose work focuses on the role of metals in biological systems. He is best known for his work on the anti-cancer drug cisplatin, which contains platinum and is a first-line therapy for many cancers. His foundational work on platinum-based anticancer drugs has paved the way for other researchers working to develop cancer treatments. Dr. Lippard’s work has also helped advance cleaner fuel technologies, and shed light on the role of metal ions in signaling processes in the brain. Within the chemistry community, Dr. Lippard is famous for the superb mentorship he provides his students, many of whom now have groundbreaking careers of their own in the field. Dr. Stephen Lippard is an alumnus of Haverford College, where he says his love of chemistry took root. He will be interviewed by fellow Haverford alumnus Ted W. Love the CEO of Global Blood Therapeutics. This event was supported by the National Science Foundation and the United States Patent and Trademark Office.
Dr. Lippard is the Arthur Amos Noyes Professor Emeritus of Chemistry at MIT whose work focuses on the role of metals in biological systems. He is best known for his work on the anti-cancer drug cisplatin, which contains platinum and is a first-line therapy for many cancers. His foundational work on platinum-based anticancer drugs has paved the way for other researchers working to develop cancer treatments. Dr. Lippard’s work has also helped advance cleaner fuel technologies, and shed light on the role of metal ions in signaling processes in the brain. Within the chemistry community, Dr. Lippard is famous for the superb mentorship he provides his students, many of whom now have groundbreaking careers of their own in the field. Dr. Stephen Lippard is an alumnus of Haverford College, where he says his love of chemistry took root. He will be interviewed by fellow Haverford alumnus Ted W. Love the CEO of Global Blood Therapeutics. This event was supported by the National Science Foundation and the United States Patent and Trademark Office.